January 23, 2022

Multi-Year Contracts, Results Schedules, and Financial Guidance Updates

Pin It

financial_reports-757x332– Research Report on Cigna, PerkinElmer, WuXi PharmaTech, MEDNAX, and WellCare

By Analysts’ Corner

NEW YORK, January 15, 2014 — /PRNewswire/ —

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts’ Corner announced new research reports highlighting Cigna Corporation (NYSE: CI), PerkinElmer, Inc. (NYSE: PKI), WuXi PharmaTech (Cayman) Inc. (NYSE: WX), MEDNAX, Inc. (NYSE: MD), and WellCare Health Plans, Inc. (NYSE: WCG). Today’s readers may access these reports free of charge – including full price targets, industry analysis and analyst ratings – via the links below.

Cigna Corporation Research Report

On January 6, 2014, Cigna Corporation (Cigna) announced that it has entered into a multi-year contract with the University of Mississippi Medical Center (UMMC). The Company stated that as part of the contract, UMMC and its employed physicians will be added to Cigna’s network of participating hospitals and doctors in Jackson, Mississippi. Rich Novack, President and General Manager for MidSouth markets, stated, “We are pleased to expand our offerings across Mississippi with the addition of the University of Mississippi Medical Center to our network and look forward to continuing to provide access to quality, customer-focused and affordable health care.” Dr. James E. Keeton, Vice Chancellor for Health Affairs and Dean of the School of Medicine at UMMC, added, “We’re delighted that Cigna customers now have in-network access to the services of Mississippi’s only academic medical center.” The Full Research Report on Cigna Corporation – including full detailed breakdown, analyst ratings and price targets – is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/7307_CI

PerkinElmer, Inc. Research Report

On January 8, 2014, PerkinElmer, Inc. (PerkinElmer) announced that it will release its Q4 2013 results on January 30, 2014, after market close. The Company stated that in order to discuss the results, it has scheduled a conference call at 5:00 p.m. ET on the same day, which will be hosted by PerkinElmer Chairman and CEO Robert F. Friel, and Senior Vice President and CFO Andy Wilson. PerkinElmer added that a live audio webcast of the call can be accessed via the Investor section of the Company’s website. The Full Research Report on PerkinElmer, Inc. – including full detailed breakdown, analyst ratings and price targets – is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/2016_PKI

WuXi PharmaTech (Cayman) Inc. Research Report

On January 10, 2014, WuXi PharmaTech (Cayman) Inc. (WuXi PharmaTech) announced updates to its 2013 financial guidance. The Company stated that for full-year 2013, it expects total revenues of approximately $578 million, and diluted EPS to slightly exceed the top end of its previous guidance of $1.51 to $1.55 (GAAP) and $1.73 to $1.77 (non-GAAP). WuXi PharmaTech also informed that it plans to report its Q4 2013 and full-year 2013 financial results, along with 2014 financial guidance, in March 2014. The Company further announced that it will present at the 32nd annual J.P. Morgan Healthcare Conference on January 15, 2014 at 8:30 a.m. PST. The Full Research Report on WuXi PharmaTech (Cayman) Inc. – including full detailed breakdown, analyst ratings and price targets – is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/df7b_WX

MEDNAX, Inc. Research Report

On January 10, 2014, MEDNAX, Inc. (MEDNAX) announced that it will release its Q4 2013 and full-year 2013 financial results on January 30, 2014, before the securities markets open. The Company added that it will host an investor conference call and webcast at 10:00 a.m. EST on the same day to discuss the results. MEDNAX informed that the webcast of the call will be available through its website. The Full Research Report on MEDNAX, Inc. – including full detailed breakdown, analyst ratings and price targets – is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/671d_MD

WellCare Health Plans, Inc. Research Report

On January 9, 2014, WellCare Health Plans, Inc. (WellCare) announced that it will release its Q4 2013 and full-year 2013 results on February 12, 2014 at 6:30 a.m. ET. The Company stated that CEO Dave Gallitano will discuss the results starting at 8:30 a.m. ET, which will be webcast live via the Company’s website. WellCare added that a replay will be available via webcast for 30 days on its website. The Full Research Report on WellCare Health Plans, Inc. – including full detailed breakdown, analyst ratings and price targets – is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/be48_WCG

—-

EDITOR NOTES:

This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]

For any urgent concerns or inquiries, please contact us at [email protected]

Read more here: http://www.sacbee.com/2014/01/15/6073734/multi-year-contracts-results-schedules.html#storylink=cp

Print Friendly, PDF & Email
About ieyenews

Speak Your Mind

*